ocular immunology kyle c. mckenna, ph. d. associate professor of biology and opthalmology franciscan...

29
Ocular Immunology Kyle C. McKenna, Ph. D. Associate Professor of Biology and Opthalmology Franciscan University of Steubenville University of Pittsburgh School of Medicine [email protected] [email protected]

Upload: janice-richardson

Post on 21-Jan-2016

219 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Ocular Immunology Kyle C. McKenna, Ph. D. Associate Professor of Biology and Opthalmology Franciscan University of Steubenville University of Pittsburgh

Ocular Immunology

Kyle C. McKenna, Ph. D.Associate Professor of Biology and Opthalmology

Franciscan University of SteubenvilleUniversity of Pittsburgh School of Medicine

[email protected]@upmc.edu

Page 2: Ocular Immunology Kyle C. McKenna, Ph. D. Associate Professor of Biology and Opthalmology Franciscan University of Steubenville University of Pittsburgh

HypopyonOcular infiltrate of white blood cells(leukocytes) which settle via gravityto the bottom of the anterior chamber“like sands through the hour glass”

How did the leukocytes get there?

Leukocytes (cells of the immune system travelVia blood and enter the eye via vessels in theiris, ciliary body, choroid, retina, and sclera

Page 3: Ocular Immunology Kyle C. McKenna, Ph. D. Associate Professor of Biology and Opthalmology Franciscan University of Steubenville University of Pittsburgh

Blood Smear

Basophil

MonocyteBand Cell

Eosinophil

Lymphocyte

Lymphocyte

Neutrophil

Neutrophil

1

2

34 5

65

1

Page 4: Ocular Immunology Kyle C. McKenna, Ph. D. Associate Professor of Biology and Opthalmology Franciscan University of Steubenville University of Pittsburgh

Granulocytes

Neutrophil Eosinophil Basophil

Mast Cells

Monocytes

Macrophages

Lymphocytes

B CellsT Cells

T T

CD4+Thelper

CD8+CTL

Adaptive ImmunityInnate Immunity

Complement

Antibody

Page 5: Ocular Immunology Kyle C. McKenna, Ph. D. Associate Professor of Biology and Opthalmology Franciscan University of Steubenville University of Pittsburgh

• Immediate• Includes anatomical

and biochemical barriers

• Recognition of conserved pathogen associated molecular patterns (PAMPs)

• No memory generation

• Delayed• Specific recognition of

pathogenic molecules• Memory Generation

Innate Adaptive

Page 6: Ocular Immunology Kyle C. McKenna, Ph. D. Associate Professor of Biology and Opthalmology Franciscan University of Steubenville University of Pittsburgh

PAMP PRRPathogen Recognition Receptor

Lipopolysaccharide (LPS) TLR 4Toll Like Receptor

Double Stranded RNA TLR 3

DAMPDamage associated molecular pattern

DRRDamage Recognition Receptor

HMGB1(High MobilityGroup box 1)

RAGE, TLR 2, 4 and 9Receptor of advanced glycation endproduct

Nonoxidized (reduced) HMGB1 is released by normal cells upon necrotic butNot apoptotic cell death

Page 7: Ocular Immunology Kyle C. McKenna, Ph. D. Associate Professor of Biology and Opthalmology Franciscan University of Steubenville University of Pittsburgh

PAMPs and DAMPs promote inflammation

IL-1IL-6

TNFNitric oxide

IL-8

Increased Cell Surface moleculesMHC Class I & IICD40, CD80, CD86

Produce inflammatory cytokinesIL-12TNF

Activated Antigen PresentingCells Leave via afferent lymphatics

MacsDC

RednessSWELLINGPAIN

Page 8: Ocular Immunology Kyle C. McKenna, Ph. D. Associate Professor of Biology and Opthalmology Franciscan University of Steubenville University of Pittsburgh

Spleen

Secondary Lymphoid Organs

Page 9: Ocular Immunology Kyle C. McKenna, Ph. D. Associate Professor of Biology and Opthalmology Franciscan University of Steubenville University of Pittsburgh

Innate immunity is immediate but alone insufficient for pathogen control

Page 10: Ocular Immunology Kyle C. McKenna, Ph. D. Associate Professor of Biology and Opthalmology Franciscan University of Steubenville University of Pittsburgh

Adaptive ImmunityB-Cells T-Cells

Antigen Receptor: Immunoglobulin TCRRecognition: Proteins, Carbohydrates

Lipids, most any moleculeProcessed Proteins Presented as

Peptides via MHC molecules by APC

ExogenousProteins via

MHC Class II

EndogenousProteins via

MHC Class I

ProfessionalAPC

All Cells inBody

Page 11: Ocular Immunology Kyle C. McKenna, Ph. D. Associate Professor of Biology and Opthalmology Franciscan University of Steubenville University of Pittsburgh

From Eye

APC

FreeAntigen

Page 12: Ocular Immunology Kyle C. McKenna, Ph. D. Associate Professor of Biology and Opthalmology Franciscan University of Steubenville University of Pittsburgh

B

B

B

BB

B

B

B

B

T

T

T

T

T

T

T

T

T

T

TT

T

T

FDC

More ProliferationHere

Page 13: Ocular Immunology Kyle C. McKenna, Ph. D. Associate Professor of Biology and Opthalmology Franciscan University of Steubenville University of Pittsburgh

Clonal Expansion

Diverse RepertoireOf B cells and T cell

Increase NumbersOf Antigen Specific

Clones

Differentiation

Memory Cells

Antibody SecretingPlasma Cells

T helper Subsets

CTL

Process of Expansion and Differentiation takes time which is why AdaptiveImmunity is Delayed

Eff

ecto

rs

APC

Page 14: Ocular Immunology Kyle C. McKenna, Ph. D. Associate Professor of Biology and Opthalmology Franciscan University of Steubenville University of Pittsburgh

CD4+T helper

IL-2

IL-2IFN

CD8+CTL

Lytic granulesContaining Granzyme B Lysis of infected Cells

IFN

B cells

IgG2aViral and Bacterial infections

IL-4, 5, 6, 10

B cells

IgG, IgEExtracellular Helminthic Infections

What determines uniqueThelper differentiation?

PAMPS / APC

APCIL-12

LPS/TLR4

TH1

APCIL-4

Filaria?

TH2

Page 15: Ocular Immunology Kyle C. McKenna, Ph. D. Associate Professor of Biology and Opthalmology Franciscan University of Steubenville University of Pittsburgh

Infections Activate InnateImmunity via PAMPS

T and B cell expansionAnd differentiation occur

Blood Stream

Activated APCLeave eye CarryingPathogenic Molecules

AfferentLymphatics

LymphNode

EfferentLymphatics

Page 16: Ocular Immunology Kyle C. McKenna, Ph. D. Associate Professor of Biology and Opthalmology Franciscan University of Steubenville University of Pittsburgh

What is Type I Hypersensitivity?

Immediate Hypersensitivity

Antibody Mediated (IgE)

IgE molecules are bound by FcEpsilon receptors on Mast Cells

Mast Cells release histamines which promote inflammation

Allergic Conjunctivitis

Page 17: Ocular Immunology Kyle C. McKenna, Ph. D. Associate Professor of Biology and Opthalmology Franciscan University of Steubenville University of Pittsburgh

What is Type II Hypersensitivity?

Antibody Mediated

Cell lysis via Antibody Dependent Cellular Cytotoxicity

Rh Hemolytic anemia in newborns

Sympathetic ophthalmia, Uveitis

CompMAC

Phagocytosis

Page 18: Ocular Immunology Kyle C. McKenna, Ph. D. Associate Professor of Biology and Opthalmology Franciscan University of Steubenville University of Pittsburgh

What is Type III Hypersensitivity?

Antibody Complex Mediated

Antibody Complexes Fix Complement Leading to productionOf anaphylotoxins which promote inflammation

CompMAC

CompMAC

CompMAC C3a, C5a

AnaphlotoxinsPromote vasodilationAnd leukocyteinfiltration

Page 19: Ocular Immunology Kyle C. McKenna, Ph. D. Associate Professor of Biology and Opthalmology Franciscan University of Steubenville University of Pittsburgh

What is Type IV Hypersensitivity?

Delayed Type Hypersensitivity

T cell mediated (CD4 TH1 cells)

CD4+ T cells activate macrophages to release inflammatory mediators(TNFa, Nitric Oxide) which causes nonspecific damage of innocent bystanderTissues

Promote infiltration of neutrophils which further enhance inflammation

CD4+T helper MAC

IFN

Nitric OxideTNF

Page 20: Ocular Immunology Kyle C. McKenna, Ph. D. Associate Professor of Biology and Opthalmology Franciscan University of Steubenville University of Pittsburgh

What is Type V Hypersensitivity?

Antibodies are generated which are stimulatory

Graves DiseaseAnti-thyroid stimulating hormone receptor antibodiesstimulate the effects of Thyroid Stimulating Hormone

TSH

TSHR

Antibody

Page 21: Ocular Immunology Kyle C. McKenna, Ph. D. Associate Professor of Biology and Opthalmology Franciscan University of Steubenville University of Pittsburgh

TCR and Immunoglobulin molecules are generated by Random Somatic Rearrangement of gene segments

What is the potential complication of this process?

Generation of TCR and Immunoglobulin molecules that recognize self tissues

Page 22: Ocular Immunology Kyle C. McKenna, Ph. D. Associate Professor of Biology and Opthalmology Franciscan University of Steubenville University of Pittsburgh

T cells expressing TCR with strong reactivity to self antigens are deletedIn the Thymus during T cell development

What is the consequence of overly stringent negative selection?

Decreased Repertoire of the T cell pool

Page 23: Ocular Immunology Kyle C. McKenna, Ph. D. Associate Professor of Biology and Opthalmology Franciscan University of Steubenville University of Pittsburgh

Fact: T cells and B cells are generated with receptors that demonstratesome affinity for self antigens.

Why are we not in a constant state of autoimmunity?

Peripheral tolerance mechanisms

Page 24: Ocular Immunology Kyle C. McKenna, Ph. D. Associate Professor of Biology and Opthalmology Franciscan University of Steubenville University of Pittsburgh

Three Signals are Required for Full T cell activation

3

Cytokines

1. TCR : MHC/peptide2. Costimulatory Molecules3. Cytokine Production

In the absence of three signalsT cell anergy or tolerance is generated

How do PAMPS break tolerance toSelf antigens?

PAMPS increase costimulatory moleculesAnd cytokine expression

Page 25: Ocular Immunology Kyle C. McKenna, Ph. D. Associate Professor of Biology and Opthalmology Franciscan University of Steubenville University of Pittsburgh

UveitisClassic T cell dependent Type IV hypersensitivity response

Infectious (syphilis, tuberculosis, toxoplasma gondii)Noninfectious (self antigens)[mouse models via immunization with IRBP, Retinal S-ag]

Disease Associations made with particular MHC moleculesHLA-B27 : Reiter’s syndromeHLA-B5: Behcet’s DiseaseHLA-29: Birdshot Choroidopathy

How could an immune response to an ocular antigen develop toCause autoimmune uveitis?

Retention of T cells with specificity to ocular antigens due toWeak negative selection in individuals with particular HLA types

Previous infection or trauma primed for ocular antigens in anInflammatory context

Molecular Mimicry (Klebsiella, Chlymidia, Yersinia?)

Page 26: Ocular Immunology Kyle C. McKenna, Ph. D. Associate Professor of Biology and Opthalmology Franciscan University of Steubenville University of Pittsburgh

Ocular Immune PrivilegeCharacterized by prolonged acceptance of foreign immunogenic graftsIn comparison to conventional sites

Corneal Allografts most successful (no matching, minimal immunosuppression required)

Experimentally immunogenic tumors grow progressively in the anteriorChamber but are eliminated by CD8+ T cells when transplanted in theskin

Page 27: Ocular Immunology Kyle C. McKenna, Ph. D. Associate Professor of Biology and Opthalmology Franciscan University of Steubenville University of Pittsburgh

Anatomical Barriers to Host Immune Response

Cornea is avascular

Interior of Eye lacks demonstrable lymphatic drainage

Blood Aqueous Barrier

Blood Retinal Barrier

Page 28: Ocular Immunology Kyle C. McKenna, Ph. D. Associate Professor of Biology and Opthalmology Franciscan University of Steubenville University of Pittsburgh

Biochemical Barriers to Host Immune Response

Aqueous Humor contains Immunosuppressive soluble factors(TGF-, -MSH, IL-10, MIF, CGRP, VIP, somatostatin)

Interior Cell Surface expresses Death inducing Molecules(FasL, Trail, PD-1 and PD-2L)

T cell anergy, T cell death, T regulatory generation

Page 29: Ocular Immunology Kyle C. McKenna, Ph. D. Associate Professor of Biology and Opthalmology Franciscan University of Steubenville University of Pittsburgh

Tolerance Induction to Ocular Antigens

Introduction of foreign antigens into the anterior chamber, subretinal spaceAnd vitreous cavity induces systemic tolerance to these antigens

Mediated by the generation of Tregulatory cellsCD4, CD8+

and Regulatory B cells